Hans Hull Insider Trading $ADVM Adverum Biotechnologies, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Hans Hull.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Hans Hull. Hans Hull is Chief Executive Officer in Adverum Biotechnologies, Inc. ($AAVL) and SVP, Business Operations in Adverum Biotechnologies, Inc. ($AAVL) and SVP, Legal and Corp. Dev. in Adverum Biotechnologies, Inc. ($AAVL) and Chief Business Officer in PLIANT THERAPEUTICS, INC. ($PLRX).

Hans Hull in Adverum Biotechnologies, Inc.

Trading Symbol: ADVM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hans Hull: Chief Executive Officer, SVP, Business Operations, SVP, Legal and Corp. Dev.
Holdings: 137,210 shares
Latest Transaction: Aug 25 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Hans Hull in Adverum Biotechnologies, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, PLRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 25 2015AAVLAdverum Biotechnol ...Hull HansChief Executive Off ...GrantA0.00117,5900137,21019.6 K to 137.2 K (+599.34 %)
Jun 16 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...Option ExerciseM0.198,3001,57712,200
Jun 16 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...BuyM0.198,3001,57719,62011.3 K to 19.6 K (+73.32 %)
Jun 05 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...Option ExerciseM0.192,00038020,500
Jun 05 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...SellS37.642,00075,28311,32013.3 K to 11.3 K (-15.02 %)
Jun 05 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...BuyM0.192,00038013,32011.3 K to 13.3 K (+17.67 %)
May 06 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...Option ExerciseM0.195,00095022,500
May 06 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...SellS30.875,000154,34911,32016.3 K to 11.3 K (-30.64 %)
May 06 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...BuyM0.195,00095016,32011.3 K to 16.3 K (+44.17 %)
Apr 23 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...Option ExerciseA39.3523,000905,05023,000
Apr 23 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...GrantA0.008,000011,3203.3 K to 11.3 K (+240.96 %)
Apr 08 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...Option ExerciseM0.1927,5005,22527,500
Apr 08 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...SellS39.0688734,6463,3204.2 K to 3.3 K (-21.08 %)
Apr 08 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...SellS38.5926,6131,026,9264,20730.8 K to 4.2 K (-86.35 %)
Apr 08 2015AAVLAdverum Biotechnol ...Hull HansSVP, Business Opera ...BuyM0.1927,5005,22530,8203.3 K to 30.8 K (+828.31 %)
Aug 07 2014AAVLAdverum Biotechnol ...Hull HansSVP, Legal and Corp ...Option ExerciseC0.003,32000
Aug 07 2014AAVLAdverum Biotechnol ...Hull HansSVP, Legal and Corp ...BuyC0.003,32003,3200 to 3.3 K
Aug 01 2014AAVLAdverum Biotechnol ...Hull HansSVP, Legal and Corp ...Option ExerciseA17.0075,0001,275,00075,000

Page:   1